Cardiovascular Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 549 Agreements Signed Since 2016 - ResearchAndMarkets.com
Cardiovascular Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the cardiovascular deals entered into by the worlds leading biopharma companies.
- Cardiovascular Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the cardiovascular deals entered into by the worlds leading biopharma companies.
- Fully revised and updated, the report provides details of 549 cardiovascular deals from 2016 to 2024.
- The report also includes numerous table and figures that illustrate the trends and activities in cardiovascular deal making since 2016.
- Directory of deals by company A-Z, therapy focus and technology type
Analyzing contract agreements allows due diligence of:
What are the precise rights granted or optioned?